B
Bullisch
Bullisch · 25%AMED
$104.36
Szenariopreis
$100.990
+0.010 (+0.01%)Zum Schluss
Loading chart…
- Hoch
- 101.020
- Eröffnung
- 101.020
- Volumengewichteter Durchschnittskurs
- 100.98
- Volumen
- 1.06M
- Marktkap.
- 3.04B
- Tief
- 100.930
- Umsatz
- 107.04M
- EV/EBITDA, TTM
- 12.17
Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.
Analystenbewertungen (11)
+2.24% Aufwärtspotenzial
Halten
5 Kaufen
6 Halten
0 Verkaufen
Aktuell: 100.99
Tief
101.00
Durchschnitt
103.25
Hoch
110.00
RBC Capital
Kaufen
$100
2025-04-16
RBC Capital
2025-04-16
Kursziel
$100
Kaufen
Stephens & Co.
Halten
$101
2025-03-04
Stephens & Co.
2025-03-04
Kursziel
$101
Halten
Stephens & Co.
Halten
$101
2025-02-12
Stephens & Co.
2025-02-12
Kursziel
$101
Halten
Deutsche Bank
Halten
$101
2024-07-31
Deutsche Bank
2024-07-31
Kursziel
$101
Halten
Cantor Fitzgerald
Halten
$101
2024-07-25
Cantor Fitzgerald
2024-07-25
Kursziel
$101
Halten
Bewertungskennzahlen
Das aktuelle erwartete KGV von Amedisys Inc (AMED) beträgt 18.61, verglichen mit dem 5-Jahres-Durchschnitt von 21.53.
Alphio-AI-Kursszenarien für AMED
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.
Event-Zeitleiste
News
5.008-15BenzingaWhy Is UnitedHealth Stock Trading Higher Friday?
2.008-15SeekingAlphaTwilio set to join S&P MidCap 400
8.008-14BenzingaUnitedHealth Group Climbs 1.17% After Hours Following $2.21 Quarterly Dividend Authorization
8.508-11BenzingaWhat's Going On With UnitedHealth Stock Monday?
8.508-08BenzingaUnitedHealth Faces Large Outpatient Divestiture To Resolve Antitrust Suit Related To Amedisys Deal
AMED FAQ – beantwortet von Alphio AI
Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
11 analysts cover AMED: 5 rate it Buy, 6 Hold and 0 Sell. The average price target is 103.25.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.